Number of cases staining positively for anti-MUC1 monoclonal antibodies in tumour cells of ALK negative lymphomas
| Lymphoma type | SM3 | VU-4H5 | DF3 | 139H2 | E29 |
|---|---|---|---|---|---|
| +++, 75–95% positive tumour cells; ++, 50–75% positive tumour cells; +/–, focal or scattered staining of <25% of tumour cells; –, no staining of tumour cells. | |||||
| ALCL, anaplastic large cell lymphoma; DLBCL, diffuse large B cell lymphoma; HD-MC, Hodgkin's disease, mixed cellularity subtype; HD-NS, Hodgkin's disease, nodular sclerosing subtype; | |||||
| PTCL-NOS, peripheral T cell lymphoma, not otherwise specified; T-LB, T lymphoblastic lymphoma. | |||||
| ALK negative systemic ALCL | – | – | 3+/– | 3+/– | 3+/– |
| Primary cutaneous ALCL | – | – | – | – | – |
| Classic HD-NS | – | – | 1+++, 1+/– | 1++, 1+/– | 1+++, 1+/– |
| Classic HD-MC | – | – | 1+/– | 1+/– | 1+/– |
| PTCL-NOS | – | – | 1+/– | 1+/– | 1+/– |
| T-LB | – | – | – | – | – |
| DLBCL | – | 1+/– | 1+++ | 1+++ | 1+++ |